ST6GAL1 and malignant colon neoplasm: It has been reported that the excessive α-2-6 sialylation on Fas receptors in colon cancer, catalyzed by ST6Gal-I, thwarts the receptor oligomerization and signaling induced by FasL and anti-CD95 antibody.